After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.
Patients from around the country have filed 100 lawsuits against Bloomington-based Cook, alleging that some of its blood-clot filters have broken apart, moved or poked through the blood vessel where they are implanted.
Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024—1.1 percentage points faster than overall economic growth, actuaries at the Centers for Medicare and Medicaid Services said Tuesday in an annual study.
During a visit to the Richard L. Roudebush VA Medical Center in Indianapolis, Robert McDonald said Thursday he thinks Congress will act to avoid shutting down some VA hospitals and other cost-cutting steps.
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer's drug.
New data released Wednesday morning suggest that Eli Lilly and Co.'s Alzheimer's drug has a modest but lasting impact on the memory-sapping disease. But analysts worry the impact is too small to be meaningful.